Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Expansion Therapeutics Logo
Expansion Therapeutics Growth Score
24
CB Rank
32490
Heat Score
18
Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.
Founded
obfuscation
PrivateVenture - Series Unknown San Diego, California, United States11-50 www.expansionrx.com/
Biotechnology
Health Care
Therapeutics
Overview

Expansion Therapeutics
Total Funding
obfuscation
Growth Score
24
Heat Score
18

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score24
-3 pts
in past quarter
Heat Score 18
-17 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Expansion Therapeutics

CB Rank
32490
Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.
Founded
obfuscation
PrivateVenture - Series Unknown San Diego, California, United States11-50 www.expansionrx.com/
Biotechnology
Health Care
Therapeutics

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name Expansion Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Kevin Forrest, Matthew D. Disney
About the Company
Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases.
Phone Number (858) 764-4290
Contact Email info@expansionrx.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

SMiRNA™ Platform
A drug discovery platform that identifies and optimizes small molecule drugs targeting disease-causing RNA structures.
Oral Small Molecule Therapeutics for RNA-Mediated Neurological Diseases
Orally administered small molecule drugs designed to modulate RNA structures involved in neurological diseases such as Myotonic Dystrophy, ALS/FTD, and Tauopathies.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Expansion Therapeutics Logo
Venture Round - Expansion Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Expansion Therapeutics Logo
Venture Round - Expansion Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Expansion Therapeutics Logo
Venture Round - Expansion Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Expansion Therapeutics Logo
Venture Round - Expansion Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Expansion Therapeutics Logo
Venture Round - Expansion Therapeutics
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Expansion Therapeutics Logo
Venture Round - Expansion Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Expansion Therapeutics Logo
Venture Round - Expansion Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Expansion Therapeutics Logo
Venture Round - Expansion Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Expansion Therapeutics Logo
Venture Round - Expansion Therapeutics
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Expansion Therapeutics Logo
Venture Round - Expansion Therapeutics
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 4 Board Members and Advisors 8 Contacts 32

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 29, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 24, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$472.9KThis year, Expansion Therapeutics is projected to spend $472.9K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
The New York Times Logo
The New York Times
84
Applecare for Enterprise Logo
Applecare for Enterprise
83
Statement of Work Software Logo
Statement of Work Software
80

Actively Used Products

16Expansion Therapeutics uses 16 technology products and services including HTML5, Google Analytics, and  GoDaddy Premium DNS, according to G2 Stack.

Active Website Tech Count

15Expansion Therapeutics is actively using 15 technologies for its website, according to BuiltWith. These include Organization Schema, SPF, and  CommonCrawl Top 5m.

Total IP

2The intellectual property of Expansion Therapeutics includes 2 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Expansion Therapeutics's headquarters? Expansion Therapeutics is located in San Diego, California, United States.Who invested in Expansion Therapeutics? Expansion Therapeutics has 10 investors including 5AM Ventures and  Sanofi Ventures.When was the last funding round for Expansion Therapeutics? Expansion Therapeutics closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Expansion Therapeutics's competitors? Alternatives and possible competitors to Expansion Therapeutics may include Juvena Therapeutics, Mahzi Therapeutics, and  AcuraStem.How much funding has Expansion Therapeutics raised to date? Expansion Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|